MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

10,12-Tricosadiynoic acid

CAS No. : 66990-30-5

MCE 站：10,12-Tricosadiynoic acid

产品活性：10,12-Tricosadiynoic acid 是一种高特异性，选择性，高亲和力且具有口服活性的酰基辅酶 A 氧化酶-1 (ACOX1) 抑制剂。10,12-Tricosadiynoic acid 可改善线粒体脂质和 ROS 代谢，可用于高脂饮食或肥胖引起的代谢性疾病的研究。

研究领域：Metabolic Enzyme/Protease

作用靶点：Acyltransferase

In Vitro: 10,12-Tricosadiynoic acid-CoA rapidly inhibits ACOX1 activity in a time- and concentration-dependent manner. The activity of ACOX1 decreases by nearly 95% after 5 min of incubation with 10 eq of 10,12-Tricosadiynoic acid-CoA. ACOX1 activity is inhibited only if free 10,12-Tricosadiynoic Acid is activated as the CoA thioester, the substrate form. Inhibition of ACOX1 by 10,12-Tricosadiynoic acid-CoA is irreversible. And the kinetics parameters KI and kinact are calculated to be 680 nm and 3.18 min^?1, respectively.
10,12-Tricosadiynoic acid is the precursor of 10,12-Tricosadiynoic acid-CoA and is transformed into 10,12-Tricosadiynoic acid-CoA by peroxisomal very long chain acyl-CoA synthetase (VLACS) after entering into cells, and it inhibits ACOX1 in vivo.
10,12-Tricosadiynoic acid (500 nM) inhibits acyl-CoA oxidase-1 (ACOX1) activity. 10,12-Tricosadiynoic acid treatment abrogates the protective effect by Sirt5 siRNA.

In Vivo: 10,12-Tricosadiynoic acid (100 μg/kg; oral gavage; daily; for 8 weeks; male Wistar rats) treatment increases hepatic mitochondrial fatty acid oxidation (FAO) via activation of the SIRT1-AMPK (adenosine 5′-monophosphate-activated protein kinase) pathway and proliferator activator receptor α and reduces hydrogen peroxide accumulation in high fat diet-fed rats, which significantly decreases hepatic lipid and ROS contents, reduces body weight gain, and decreases serum triglyceride and insulin levels.
10,12-Tricosadiynoic acid (0 mg/kg, 37.5 mg/kg, 75 mg/kg, and 150 mg/kg diet) treatment does not affect weight gain, but significantly decreases peroxisomal β-oxidation in the liver, and increased body fat accumulation in Nile tilapia. The fish with impaired peroxisomal β-oxidation exhibited higher contents of serum lipid and peroxidation products, and alanine aminotransferase activity, and significantly lowered hepatic activities of superoxide dismutase and catalase.

相关产品：Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Lipid Compound Library  |  Orally Active Compound Library  |  Avasimibe  |  A 922500  |  T863  |  Xanthohumol  |  K-604 dihydrochloride  |  Nevanimibe hydrochloride  |  Fumonisin B1  |  AZD3988  |  OSMI-1  |  RHC 80267  |  DGAT-1 inhibitor 2  |  Pactimibe  |  Pyripyropene A  |  RP-64477  |  2-Furoic acid  |  DL-Glyceraldehyde 3-phosphate  |  Fumonisin B2  |  Glabrol  |  RP 70676  |  YM17E  |  Beauvericin  |  Enniatin A  |  Enniatin B  |  Enniatin B1  |  Enniatin complex  |  YM-750  |  ACAT-IN-1 cis isomer  |  E-5324

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。